Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Jethwa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiation Oncology, 2015 - 2019
University of North Dakota School of Medicine and Health SciencesClass of 2014
Certifications & Licensure
RI State Medical License 2021 - 2028
MN State Medical License 2015 - 2026
CT State Medical License 2019 - 2025
ND State Medical License 2014 - 2015
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Mayo Clinic Patient Lists, Mayo Clinic, 2016-2017
- CMS Meaningful Use Stage 1 Certification Mayo Clinic Incorporate Lab Results, Mayo Clinic, 2016-2017
- CMS Meaningful Use Stage 1 Certification Mayo Clinic Electronic Notes, Mayo Clinic, 2016-2017
Publications & Presentations
PubMed
- Development of a CORe outcome set for clinical trials of RECTal cancer treatment: protocol for the CORRECT initiative.Richard Garfinkle, Manju George, Krishan Jethwa, Peter Johansen, Mary Lakaszawski
BMJ Open. 2026-04-13 - Executive Summary of the American Radium Society Appropriate Use Criteria for Selective Use of Pelvic Radiation Therapy in Locally Advanced Rectal Cancer: A Consensus ..., Leila T Tchelebi, Krishan R Jethwa, Eric Dozios, Zhaohui Jin
International Journal of Radiation Oncology, Biology, Physics. 2026-03-25 - Liver Metastasectomy in Anal Squamous Cell Carcinoma: The Mayo Clinic Experience.Noah Takacs, Conor D J O'Donnell, Nguyen Tran, Krishan Jethwa, Thomas Atwell
Current Oncology. 2026-03-10
Press Mentions
Smilow Cancer Hospital Care Center at Waterford Physician Makes ‘Top Docs’ List in ConnecticutJune 23rd, 2021- Moderately Hypofractionated Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreas Cancer with Assessment of Treatment Response Utilizing Molecular BiomarkersApril 4th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
